Strategic Alliance Magazine Q4 2017 - 12

2 018 A S A P G L O B A L A L L I A N C E S U M M I T

upon studies based on acquisitions, alliances, joint ventures, and
more from one million corporate
development deals done during
the past 26 years. Participants will
learn how those deals' strategies
have evolved through five distinct
periods-the rise of digital technologies, dot-com era, spread of social networks,
great recession, and today's return to transformational deals.

A forward-looking, interactive mini-workshop that instructs attendees on the importance and value of ramping
up their partnering is "Joint Development of Complex
Solutions Requires Extreme Partnering" led by Jan
Twombly, CSAP, president, The Rhythm of Business and
Jeff Shuman, CSAP, principal, The Rhythm of Business,
and professor of management, Bentley University. The
session shows how extreme partnering responds to the
accelerating advance of technologies combined with customer demand.

12

Ben Gomes-Casseres, CSAP, Brandeis University and author of Remix Strategy, will partner with Greg McGahan,
PwC deals partner and alliances/joint venture practice
leader, in the session "Alliances in Corporate Development: Back to the Future?" Taking the long view on where
alliance management is headed, the session will draw
STRATEGIC ALLIANCE MAGAZINE | Q4 * 2017

There are multiple progressive sessions provided by
biopharma leaders as well, highlighted by a biopharma
executive panel featuring David Thompson, CA-AM,
CAO at Eli Lilly and Company; Mark Noguchi, VP
and global head of alliances and asset management at
Roche; Casey Caperelli, head of alliance and integration
management at Amgen; Nancy Griffin, CA-AM, VP of alliances with Novartis. Additionally, sessions include Judy
Baselice, director of alliance management, Pfizer Inc. and
Brian N. Stewart, CA-AM, director of alliance management, Merck KGaA, Darmstadt, Germany, entitled
"Navigating and Effectively Managing Complex Alliances
between Large Biotech/Pharma Organizations." Another is
"How to Optimize Value and Gracefully End Alliance Relationships" led by Jeff Hurley, CA-AM, alliance management
director, Eli Lilly and Company, and Ron McRae, CSAP,
director of alliance management, Janssen Biotech. Professional partnering's broadening role is the topic of "Alliance
Management: A Growing, Enterprise-wide Activity," led by
Karen Denton, CA-AM, alliance management director,
BD&L alliance management, and Christoph Huwe, CAAM, strategic alliance manager therapeutics, global
external innovation & alliances, Bayer Pharmaceuticals.
New to Summit is GE Healthcare Digital's R. Lynn Richard, CSAP, on "The Power of Three," and Mark Roberts
PhD, Covance Drug Development Business with the
session "Partnerships in Drug and Diagnostics Co-Development: An Alliance of Unlikely Bedfellows."
This is just a selection of offerings being provided at
the 2018 ASAP Global Alliance Summit. For up-todate information on sessions, conference agenda,
and speakers as they are announced, as well as to
register for the event, go to http://asapsummit.org/.
http://www.asapsummit.org/
Table of Contents for the Digital Edition of Strategic Alliance Magazine Q4 2017
